Showing items 1–100
Combination therapies targeting PD-1, TIM-3, and LAG-3
Grant US-11939380-B2
United States of America
Antibodies specific to glycosylated PD-L1 and methods of use thereof
Grant US-11933786-B2
United States of America
Formulations of oxabicycloheptanes and oxabicycloheptenes
Grant US-11931354-B2
United States of America
Methods of treating tumor
Grant US-11919957-B2
United States of America
OXABICYCLOHEPTANES FOR MODULATION OF IMMUNE RESPONSE
Application EP-4324477-A2
European Patent Office
ANTI-PD-1 ANTIBODY PHARMACEUTICAL COMPOSITION AND USE THEREOF
Application EP-4190353-A4
European Patent Office
Predictive peripheral blood biomarker for checkpoint inhibitors
Grant US-11899017-B2
United States of America
Anti-ICOS antibodies
Grant US-11858996-B2
United States of America
CD112 variant immunomodulatory proteins and uses thereof
Grant US-11834490-B2
United States of America
Antibody molecules to PD-1 and uses thereof
Grant US-11827704-B2
United States of America
Anti PD-L1 antibodies
Grant US-11827707-B2
United States of America
Single domain antibodies to programmed cell death (PD-1)
Grant US-11814429-B2
United States of America
Treatment of LAG-3 positive tumors
Grant US-11807686-B2
United States of America
DLL3 binding proteins and methods of use
Grant US-11807692-B2
United States of America
Antibody molecules for cancer treatment
Grant US-11795219-B2
United States of America
PVRIG polypeptides and methods of treatment
Grant US-11795209-B2
United States of America
Treatment of indolent or aggressive B-cell lymphomas using a combination comprising BTK…
Grant US-11786529-B2
United States of America
TIM-3 antagonists for the treatment and diagnosis of cancers
Grant US-11787859-B2
United States of America
Antibodies, combinations comprising antibodies, biomarkers, uses and methods
Grant US-11779604-B2
United States of America
Antibodies to programmed cell death protein 1
Grant US-11780921-B2
United States of America
Antibodies, uses and methods
Grant US-11773175-B2
United States of America
PD-1 BLOCKADE WITH NIVOLUMAB IN REFRACTORY HODGKIN'S LYMPHOMA
Application EP-4248990-A2
European Patent Office
Method of treating lung cancer
Grant US-11767361-B2
United States of America
Nucleic acids encoding anti-OX40L antibodies
Grant US-11753479-B2
United States of America
CTLA-4 variant immunomodulatory proteins and uses thereof
Grant US-11753458-B2
United States of America
Checkpoint blockade and microsatellite instability
Grant US-11753468-B2
United States of America
Methods of cancer treatment and therapy using a combination of antibodies that bind…
Grant US-11746152-B2
United States of America
PD-L2 variant immunomodulatory proteins and uses thereof
Grant US-11732022-B2
United States of America
Compositions comprising an anti-LAG-3 antibody or an anti-LAG-3 antibody and an anti-PD-1…
Grant US-11723975-B2
United States of America
Checkpoint blockade and microsatellite instability
Grant US-11718668-B2
United States of America
Methods for treating hematologic cancers
Grant US-11708412-B2
United States of America
Treatment of B cell cancers using a combination comprising Btk inhibitors
Grant US-11701357-B2
United States of America
Cancer immunotherapy by radiofrequency electrical membrane breakdown (RF-EMB)
Grant US-11696797-B2
United States of America
Method of increasing the ratio of effector T cells to regulatory T cells in a tumor by…
Grant US-11685775-B2
United States of America
Anti-PD1 antibodies and their use as therapeutics and diagnostics
Grant US-11673951-B2
United States of America
Engineered artificial antigen presenting cells for tumor infiltrating lymphocyte expansion
Grant US-11667890-B2
United States of America
Dual function antibodies specific to glycosylated PD-L1 and methods of use thereof
Grant US-11660352-B2
United States of America
ANTI-PD-1 ANTIBODY, ANTIGEN-BINDING FRAGMENT THEREOF AND PHARMACEUTICAL USE THEREOF
Application EP-3922647-A4
European Patent Office
Checkpoint blockade and microsatellite instability
Grant US-11649287-B2
United States of America
Checkpoint blockade and microsatellite instability
Grant US-11643462-B2
United States of America
CD80 variant immunomodulatory proteins and uses thereof
Grant US-11639375-B2
United States of America
Anti-CTLA-4 antibodies and methods of use thereof
Grant US-11638755-B2
United States of America
Checkpoint blockade and microsatellite instability
Grant US-11634491-B2
United States of America
Checkpoint blockade and microsatellite instability
Grant US-11629187-B2
United States of America
Bispecific antibody for ICOS and PD-L1
Grant US-11629189-B2
United States of America
Single chain variable fragment CD3 binding proteins
Grant US-11623958-B2
United States of America
Variant ICOS ligand immunomodulatory proteins and related compositions and methods
Grant US-11613566-B2
United States of America
Immunologic treatment of cancer
Grant US-11612426-B2
United States of America
Combination therapy comprising nivolumab and ipilimumab
Grant US-11612654-B2
United States of America
Mesothelin binding proteins
Grant US-11607453-B2
United States of America
Immunotherapy for hepatocellular carcinoma
Grant US-11597768-B2
United States of America
Checkpoint blockade and microsatellite instability
Grant US-11591393-B2
United States of America
Single domain antibodies to programmed cell death protein 1 (PD-1)
Grant US-11591398-B2
United States of America
Selective histone deacetylase inhibitors for the treatment of human disease
Grant US-11584733-B2
United States of America
Anti-CSF1R antibody and anti-PD-1 antibody combination therapy for selected cancers
Grant US-11566076-B2
United States of America
Methods of treating a tumor using an anti-PD-1 antibody
Grant US-11566073-B2
United States of America
Anti-CSF1R antibody and agonistic anti-CD40 antibody combination therapy for cancer
Grant US-11559583-B2
United States of America
Anti PD-1 antibodies
Grant US-11560429-B2
United States of America
Crystalline forms of (S)-7-(1-(but-2-ynoyl)piperidin-4-yl)-2-(4-phenoxyphenyl)-4,5,6,7-tetr…
Grant US-11555038-B2
United States of America
Therapeutic immunoglobulin G4 for improved bioanalytical and bioprocessing properties
Grant US-11542337-B2
United States of America
Combination therapies of HDAC inhibitors and PD-L1 inhibitors
Grant US-11535670-B2
United States of America
Combination of a PD-1 antagonist and a RAF inhibitor for treating cancer
Grant US-11534431-B2
United States of America
ANTI-PD-1 ANTIBODIES AND COMPOSITIONS
Application EP-4105235-A1
European Patent Office
Anti-PD-L1 antibodies and their use as therapeutics and diagnostics
Grant US-11512132-B2
United States of America
Immunologic treatment of cancer
Grant US-11497544-B2
United States of America
CD80 variant immunomodulatory proteins and uses thereof
Grant US-11498967-B2
United States of America
CD80 variant immunomodulatory proteins and uses thereof
Grant US-11479609-B2
United States of America
CD155 variant immunomodulatory proteins and uses thereof
Grant US-11471488-B2
United States of America
MULTISPECIFIC BINDING MOIETIES COMPRISING NOVEL PD-1 BINDING DOMAINS
Application WO-2022212516-A1
World Intellectual Property Organisation (WIPO)
NOVEL PD-1 BINDING DOMAINS
Application WO-2022211629-A1
World Intellectual Property Organisation (WIPO)
Therapeutic bacterial composition
Grant US-11439671-B2
United States of America
TIGIT antibodies, encoding nucleic acids and methods of using said antibodies in vivo
Grant US-11440960-B2
United States of America
Combination anti-CSF1R and anti-PD-1 antibody combination therapy for pancreatic cancer
Grant US-11421034-B2
United States of America
Monoclonal antibodies to programmed death 1 (PD-1)
Grant US-11414487-B2
United States of America
Bacterial biomarker
Grant US-11376285-B2
United States of America
Anti-PD-1 antibodies and compositions
Grant US-11359018-B2
United States of America
CD80 variant immunomodulatory proteins and uses thereof
Grant US-11359022-B2
United States of America
Anti-PD-1 antibodies and methods of use thereof
Grant US-11345755-B2
United States of America
Combination therapies
Grant US-11344620-B2
United States of America
Checkpoint blockade and microsatellite instability
Grant US-11339219-B2
United States of America
Methods of treating colorectal cancer
Grant US-11332529-B2
United States of America
Checkpoint blockade and microsatellite instability
Grant US-11325974-B2
United States of America
Immunomodulatory proteins with tunable affinities
Grant US-11319359-B2
United States of America
USE OF ANTI-PD-1 ANTIBODY IN THE TREATMENT OF PATIENTS WITH COLORECTAL CANCER
Application EP-3988570-A1
European Patent Office
Single-domain antibodies to programmed cell death 1 protein (PD-1), encoding nucleic…
Grant US-11312771-B2
United States of America
Use of an anti-PD-1 antibody in combination with an anti-CD30 antibody in cancer treatment
Grant US-11299543-B2
United States of America
PVRIG POLYPEPTIDES AND METHODS OF TREATMENT
Grant EP-3259597-B1
European Patent Office
Anti-CTLA-4 antibodies and methods of use thereof
Grant US-11267889-B2
United States of America
Antibody to programmed cell death 1 (PD-1) and use thereof
Grant US-11248048-B2
United States of America
Antibodies against MICA and/or MICB and uses thereof
Grant US-11242393-B2
United States of America
CD80 variant immunomodulatory proteins and uses thereof
Grant US-11230588-B2
United States of America
ANTIBODIES SPECIFICALLY BINDING PD-1 AND THEIR USES
Grant EP-3370768-B1
European Patent Office
Cytokine profiling analysis
Grant US-11209441-B2
United States of America
Immune tolerant elastin-like peptide tetramer guided nanoparticles and methods of use
Grant US-11198722-B2
United States of America
Anti-PD1 antibodies and their use as therapeutics and diagnostics
Grant US-11186637-B2
United States of America
Method of detecting TIM-3 using antibody molecules to TIM-3
Grant US-11155620-B2
United States of America
NEW MONOCLONAL ANTIBODIES TO PROGRAMMED CELL DEATH 1 (PD-1) PROTEIN
Application RU-2757316-C2
Russian Federation
Radio-frequency electrical membrane breakdown for the treatment of high risk and…
Grant US-11141216-B2
United States of America
Programmed death 1 ligand 1 (PD-L1) binding proteins and methods of use thereof
Grant US-11141434-B2
United States of America
Showing items 1–100